Wahid, Mussarat
Pratoomthai, Benjamart
Egbuniwe, Isioma U.
Evans, Hannah R.
Babaei-Jadidi, Roya
Amartey, Jason O.
Erdelyi, Viola
Yacqub-Usman, Kiren
Jackson, Andrew M.
Morris, Jonathan C.
Patel, Poulam M.
Bates, David O.
Funding for this research was provided by:
Skin Cancer Research Fund
University of Nottingham (Vice Chancellor’s Scholarship, Vice Chancellor’s Scholarship)
Navamindradhiraj University Research Fund
Medical Research Council (MR/N01247X/1, MR/N01247X/1)
Article History
Received: 7 June 2023
Accepted: 21 August 2023
First Online: 16 November 2023
Declarations
:
: DOB and JCM are authors of patents on SRPK1 inhibitors, and own shares in companies that have rights to such inhibitors.
: Ethics approval for consent for taking blood was provided by the Local Ethics Committee (University of Nottingham).